Literature DB >> 32271125

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.

Anca Pantea Stoian1, Yajnavalka Banerjee2, Ali A Rizvi3, Manfredi Rizzo4,5.   

Abstract

Entities:  

Keywords:  COVID-19; cardiovascular disease; endothelial dysfunction; insulin resistance; obesity; type 2 diabetes

Mesh：

Year:  2020        PMID： 32271125      PMCID： PMC7196360          DOI： 10.1089/met.2020.0037

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN： 1540-4196            Impact factor:   1.894


× No keyword cloud information.
  11 in total

1.  Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS.

Authors:  J K Yang; Y Feng; M Y Yuan; S Y Yuan; H J Fu; B Y Wu; G Z Sun; G R Yang; X L Zhang; L Wang; X Xu; X P Xu; J C N Chan
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

2.  Patients' Satisfaction with and Preference for Telehealth Visits.

Authors:  Jennifer M Polinski; Tobias Barker; Nancy Gagliano; Andrew Sussman; Troyen A Brennan; William H Shrank
Journal:  J Gen Intern Med       Date:  2015-08-13       Impact factor: 5.128

3.  Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.

Authors:  J Lawton; M Blackburn; J Allen; F Campbell; D Elleri; L Leelarathna; D Rankin; M Tauschmann; H Thabit; R Hovorka
Journal:  BMC Endocr Disord       Date:  2018-02-20       Impact factor: 2.763

Review 4.  Clinical considerations for patients with diabetes in times of COVID-19 epidemic.

Authors:  Ritesh Gupta; Amerta Ghosh; Awadhesh Kumar Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-10

5.  Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.

Authors:  Jun Zhou; Jie Tan
Journal:  Metabolism       Date:  2020-03-24       Impact factor: 8.694

Review 6.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

7.  Telemedicine in the Era of COVID-19.

Authors:  Jay Portnoy; Morgan Waller; Tania Elliott
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-24

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

9.  COVID-19 and diabetes: Can DPP4 inhibition play a role?

Authors:  Gianluca Iacobellis
Journal:  Diabetes Res Clin Pract       Date:  2020-03-26       Impact factor: 5.602

10.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962
View more
  37 in total

1.  Acute surgical abdomen during the COVID-19 pandemic: Clinical and therapeutic challenges.

Authors:  Dragos Serban; Bogdan Socea; Cristinel Dumitru Badiu; Corneliu Tudor; Simona Andreea Balasescu; Dan Dumitrescu; Andra Maria Trotea; Radu Iulian Spataru; Geta Vancea; Ana Maria Dascalu; Ciprian Tanasescu
Journal:  Exp Ther Med       Date:  2021-03-22       Impact factor: 2.447

2.  Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease.

Authors:  Hadith Rastad; Hossein Karim; Hanieh-Sadat Ejtahed; Ramin Tajbakhsh; Mohammad Noorisepehr; Mehrdad Babaei; Mehdi Azimzadeh; Alireza Soleimani; Seyed Hasan Inanloo; Neda Shafiabadi Hassani; Fariba Rasanezhad; Ehsan Shahrestanaki; Zeinab Khodaparast; Hossein Golami; Mostafa Qorbani
Journal:  Diabetol Metab Syndr       Date:  2020-07-06       Impact factor: 3.320

3.  COVID-19 and diabetes management: What should be considered?

Authors:  Antonio Ceriello; Anca Pantea Stoian; Manfredi Rizzo
Journal:  Diabetes Res Clin Pract       Date:  2020-04-17       Impact factor: 5.602

Review 4.  Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.

Authors:  Celestino Sardu; Jessica Gambardella; Marco Bruno Morelli; Xujun Wang; Raffaele Marfella; Gaetano Santulli
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

Review 5.  Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.

Authors:  Domenico Nuzzo; Sonya Vasto; Luca Scalisi; Salvatore Cottone; Gaetano Cambula; Manfredi Rizzo; Daniela Giacomazza; Pasquale Picone
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

Review 6.  Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection.

Authors:  Mahnaz Norouzi; Shaghayegh Norouzi; Alistaire Ruggiero; Mohammad S Khan; Stephen Myers; Kylie Kavanagh; Ravichandra Vemuri
Journal:  Microorganisms       Date:  2021-06-03

7.  Knowledge levels among elderly people with Diabetes Mellitus concerning COVID-19: an educational intervention via a teleservice.

Authors:  Bartolomeu Fagundes de Lima Filho; Nathalia Priscilla Oliveira Silva Bessa; Ana Clara Teixeira Fernandes; Íkaro Felipe da Silva Patrício; Nadja de Oliveira Alves; Fabricia Azevedo da Costa Cavalcanti
Journal:  Acta Diabetol       Date:  2020-08-04       Impact factor: 4.280

8.  COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseases.

Authors:  N Gogate; D Lyman; K A Crandall; R Kahsay; D A Natale; S Sen; R Mazumder
Journal:  bioRxiv       Date:  2020-09-10

9.  Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.

Authors:  Saloua Elamari; Imane Motaib; Saad Zbiri; Karim Elaidaoui; Asmaa Chadli; Chafik Elkettani
Journal:  Pan Afr Med J       Date:  2020-09-08

10.  Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes.

Authors:  Pantea Stoian Anca; Peter P Toth; Peter Kempler; Manfredi Rizzo
Journal:  Int J Clin Pract       Date:  2020-11-21       Impact factor: 3.149
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.